Global bioreactors market to surpass USD 2.2 billion by 2025

April 15, 2020


According to the research report titled ‘Bioreactors Market Size By Cell, By Molecule, By Technology, By End-Use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report LLC, the global bioreactors market is expected to cross USD 2.2 billion by the year 2025.
 

Rising R&D activities, growing elderly population and increased pervasiveness of chronic conditions have enhanced the biopharmaceutical industry, hence propelling bioreactors market growth. Rapid expansion of biologics, advancements in bioreactors technology and growing inclination towards personalized medicines and orphan drugs are fueling the demand for bioreactors. Increasing collaborations between material & component suppliers and bioreactor manufacturers to develop high performance and quality products is also augmenting the market outlook.
 

As per cell type, mammalian cells segment held 75% market share in 2018 and is presumed to expand continuously during the estimated timeframe. Increasing application of mammalian cells for producing viral vaccines and therapeutic proteins is aiding the segmental growth.
 

Alternatively, bacterial and yeast cells segments are predicted to showcase a decent growth rate during 201-2025, primarily due to their benefit such as superior expression levels, high osmolality tolerance, by-product concentration and ease of culture.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/448834/
 

In terms of molecule type, monoclonal antibodies segment accrued USD 270 million in 2018 and will witness consistent growth during the study period. Rising use of monoclonal antibodies for treating gastrointestinal inflammatory disease, leukemia, psoriasis, rheumatoid arthritis, breast cancers and asthma is contributing towards the segmental share.
 

The report states that wave-induced motion single-use bioreactors technology segment held 50% revenue share in 2018 owing to its wide use in modern biotechnological processes. Meanwhile, stirred SUB segment is set to record a growth rate of 17% through 2025. The technology can minimize the scale-up risks as well as maintain clean environment during the production.
 

As per regional analysis, Europe bioreactors market was worth USD 284 million in 2018. High concentration of industry players and escalating healthcare expenditure are promoting the business scenario in Europe. Favorable approval scenario for biopharmaceutical products along with advancements in bioprocess equipment are also aiding Europe market growth.
 

Major companies operating in bioreactors market are Merck Millipore, Eppendorf, Thermo Fisher Scientific, GE Healthcare and Sartorius among others.


Frequently Asked Questions (FAQ) :

Rapid expansion of biologics and biopharmaceutical industry, advancements in bioreactors technology and growing inclination towards personalized medicines and orphan drugs are fueling the bioreactors market growth.
Monoclonal antibodies are being used widely for treating gastrointestinal inflammatory disease, leukemia, psoriasis, rheumatoid arthritis, breast cancers and asthma.
High concentration of key industry players and escalating healthcare expenditure are promoting the business scenario in Europe. Favorable approval scenario for biopharmaceutical products along with advancements in bioprocess equipment are also aiding market growth.
Prominent market players are Merck Millipore, Eppendorf, Thermo Fisher Scientific, GE Healthcare and Sartorius among others.